Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/14/2025

Management of Respiratory Infections in Children

Initial Assessment and Diagnostic Approach

  • The American Thoracic Society recommends evaluating for signs of respiratory distress that would require hospital admission, including markedly raised respiratory rate, grunting, intercostal recession, breathlessness with chest signs, cyanosis, severe dehydration, altered conscious level, or signs of septicemia 3, 4
  • The British Thoracic Society suggests checking vital signs, particularly respiratory rate (concerning if >50 breaths/min) and oxygen saturation (concerning if <92%) 3
  • Assess hydration status and ability to take oral fluids, as recommended by the Thorax journal 3
  • Evaluate for specific cough characteristics that might suggest particular etiologies (barking/brassy, paroxysmal, staccato, honking), as suggested by the Chest journal 5

Treatment Approach

  • The Infectious Diseases Society of America recommends providing antipyretics for fever and pain relief, such as acetaminophen 10-15 mg/kg every 4-6 hours (not exceeding 5 doses in 24 hours) 1
  • The American Academy of Pediatrics suggests ensuring adequate fluid intake and observing for worsening symptoms 1, 3
  • For suspected bacterial pharyngitis, the Infectious Diseases Society of America recommends amoxicillin as first choice for children under 5 years (90 mg/kg/day in 2 doses) 6
  • For children 5 years and older, consider macrolide antibiotics as first-line empirical treatment, such as azithromycin 10 mg/kg on day 1, followed by 5 mg/kg/day once daily on days 2-5 6

Hospital Management

  • The British Thoracic Society recommends oxygen therapy if saturation is ≤92% 3
  • Provide intravenous fluids if needed (at 80% basal levels with electrolyte monitoring), as suggested by the Thorax journal 3
  • Appropriate antibiotics based on suspected pathogen, such as IV co-amoxiclav, cefuroxime, or cefotaxime for severe pneumonia 3

Follow-up and Monitoring

  • The American Thoracic Society recommends reviewing children treated at home if deteriorating or not improving after 48 hours 3
  • Provide families with information on managing fever, preventing dehydration, and identifying signs of deterioration, as recommended by the Thorax journal 3
  • Monitor for complications such as parapneumonic effusion if the child remains febrile or unwell after 48 hours of treatment 3